Developing What Works Best
BID Learning Network
LearningSharingDeveloping What Works Best BID Learning Network


Feb 12, 2018

World must act fast to prevent pandemic diseases – U.N. risk chief

The world must ramp up efforts to prevent huge infectious disease outbreaks – such as flu strains that can jump from animals to humans – which could kill millions of people, the chief of the U.N.’s disaster risk agency said on Saturday.

Full Story

Feb 7, 2018

What if we could develop vaccines that prevent poverty?

There’s no doubt that vaccines save lives and deliver amazing health benefits. Since 1990, the number of children around the world who die before their fifth birthday has fallen by more than half, thanks in large part to routine immunization against an array of infectious diseases.

Full Story

Jan 24, 2018

“It doesn’t have to be like ripping off a Band-Aid”: Transitioning from paper to digital records

During the 2017 Global Digital Health Forum session on Injecting Digital Technology into Old-School Immunization Systems, Dawn Seymour from PATH discussed the value of electronic immunization registries. Despite the benefits of such registries, including more accurate data, she and her colleagues Sang Dao Dinh and Hieu Tran explained some challenges when transitioning from legacy, paper-based systems in Zambia, Tanzania, and Vietnam to digital versions.

Full Story

Jan 19, 2018

Tracking progress to address antimicrobial resistance

Antimicrobial resistance (AMR) occurs when a microorganism (such as bacteria, viruses, fungi and parasites) evolves to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. While the evolution of AMR is a natural and inevitable process, the rate and spread of AMR has been accelerated by the inappropriate use of antibiotics.

Full Story

Jan 19, 2018

Zambia says new cases dropping in deadly cholera outbreak

Zambia has struggled to contain one of its deadliest cholera outbreaks in years, sending soldiers into a slum last week to keep order, collaborating with the World Health Organization on a vaccination program and even declaring a week of prayer.

Full Story

Jan 18, 2018

Panacea Biotech, Serum collaborate on six-in-one vaccine

Vaccine maker Panacea Biotec has signed two long-term agreements with Serum Institute of India and its wholly-owned subsidiary Bilthovan Biologicals BV, involving a fully liquid six-in-one vaccine. Under the collaboration, Serum will be allowed to make and sell fully liquid Whole cell Pertussis (wP) and Salk-based Injectable Polio Vaccine (IPV) based Hexavalent vaccine (DTwP-HepB-Hib-IPV) developed and commercialised by Panacea Biotec, touted to be the first of its kind, a joint note said.

Full Story

Jan 5, 2018

WHO approves a safe, inexpensive typhoid vaccine

A new, highly effective typhoid vaccine — the only one safe for infants — has been approved for global use by the World Health Organization. The approval was given in December but announced on Wednesday.

Full Story

Dec 27, 2017

1 in 10 infants worldwide did not receive any vaccinations in 2016

Worldwide, 12.9 million infants, nearly 1 in 10, did not receive any vaccinations in 2016, according to the most recent WHO and UNICEF immunization estimates. This means, critically, that these infants missed the first dose of diphtheria-tetanus-pertussis (DTP)-containing vaccine, putting them at serious risk of these potentially fatal diseases.

Full Story

Dec 26, 2017

Measles deaths fall to a record low worldwide

For the first time in history, annual deaths around the globe from measles have fallen below 100,000, the World Health Organization announced this year. As recently as the 1980s, measles killed 2.6 million people a year.

Full Story

Dec 12, 2017

“Supermalaria” is on the way

There has been growing hope in recent years that malaria could eventually be eradicated but that sense of optimism is currently facing some major new challenges. Scientists are warning that a “supermalaria” parasite is spreading rapidly across Southeast Asia, and could pose a global health threat if it spreads to Africa. It is resistant to artemisinin, the recommended first-line treatment for malaria. In addition, if the U.S. Congress carries out the proposed 44 percent cut to the President’s Malaria initiative (PMI) funding, it could have a significantly undercut prevention and treatment programs. Projections show that the PMI cut alone could lead to an additional 300,000 malaria deaths over the next four years.

Full Story